ADVANCED WOUND MANAGEMENT

BIOBRANE◊ Temporary Biosynthetic Wound Dressing

GMC1893-BIOBRANE-WEBSITE-0076-LARGE-RGB-HERO-1000PX.png

The Procedure

Recovery Information

Risks

Disclaimers

*Please refer to the instructions for use (IFU) for appropriate use.

**Compared to Silver Sulfadiazine (SSD). BIOBRANE 9.5-13.7 days vs SSD 11.2-21.3 days.
***Compared to Silver Sulfadiazine (SSD).
****Compared to Silver Sulfadiazine (SSD); p<0.001.

 

Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Smith+Nephew representative or distributor if you have questions about the availability of Smith+Nephew products in your area. For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s applicable Instructions for Use (IFU) prior to use.
Citations
  1. Erdman D, et al. Burns. 1996;22(2):141-146.
  2. Lo CH, et al. J Plast Reconstr Aesthet Surg. 2019;72(3):427-437.
  3. Muganza A, et al. Glob J Med Res. 2014;14(6):5-12.
  4. Farroha A, et al. Ann Burns Fire Disasters. 2013;XXVI(2):94-97.
  5. Lesher AP, et al. J Pediatr Surg. 2011;46(9):1759-1763
  6. Yang J-Y, et al. Burns. 1989;15(3):197-203.
  7. Cassidy C, et al. Burns. 2005;31(7):890-893.
  8. Barret JP, et al. Plastic and Reconstructive Surgery. 2000;105(1):62-65.
  9. Gerding RL, et al. J Trauma. 1988;28(8):1265-1269.
  10. Wasiak J, et al. Cochrane Database Syst Rev. 2008(4).
  11. Kumar RJ, et al. ANZ J Surg. 2004;74(8):622-626.
  12. Austin RE, et al. Burns. 2015;41(4):749-753.
  13. Lang EM, et al. Ann Plast Surg. 2005;55(5):485-489.
  14. Lal B, et al. Shock (Augusta, Ga). 2000;14(3):314-318; 318- 319.
  15. Gerding RL, et al. J Trauma. 1990;19(2):121-124.
  16. Smith+Nephew 2020. Internal Report. EO.AWM.PCS229.001.v1.
  17. Wood F, et al. Burns, 2012; 38(6): 830-839.

Title

Text

Explore